Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

281
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
281
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
278
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

451
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
451
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

653
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
653
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

208
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
208
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

632
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
632

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accurate 3D recording: Integrating ground-based LiDAR data and 3D segmentation network to extract 3D traits and analyze genetics in wheat populations.

Plant phenomics (Washington, D.C.)·2026
Same author

Theoretical investigation of active dual-band tuning of dielectric chiral metasurfaces via Q-BICs.

Optics express·2026
Same author

Combining RGB imaging with a two-stage deep learning method to reveal genetic variation of wheat sprouting traits.

Plant phenomics (Washington, D.C.)·2026
Same author

Systematic multi-component profiling of Xiangju Rupining Capsule via online comprehensive two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry coupled with stepwise acquisition workflow and multivariate data mining.

Journal of chromatography. A·2026
Same author

Amphiphilic Ebselen Conjugate Suppresses Tripartite Motif-Containing 21-Glutathione Peroxidase 4 Axis-Dependent Neuronal Ferroptosis and Ameliorates Epilepsy.

ACS nano·2026
Same author

Ferroptosis-associated transcriptional factors in neurological diseases: molecular mechanisms and therapeutic prospects.

Experimental & molecular medicine·2025

Related Experiment Video

Updated: Sep 13, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.2K

Potential causal link between antiseizure medication targets and cognitive function: A mendelian randomization study.

Kun Zhu1, Jian Yu2, Junyan Liu3

  • 1Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|July 30, 2025
PubMed
Summary

Antiseizure medications (ASMs) can affect cognitive function. This study used Mendelian randomization to find that the expression of carbonic anhydrase 13 (CA13), an ASM target, is linked to cognitive performance and fluid intelligence.

Keywords:
Antiseizure medicationCausal linkCognitive functionMendelian randomization

More Related Videos

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

33.5K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

514

Related Experiment Videos

Last Updated: Sep 13, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.2K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

33.5K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

514

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • Antiseizure medications (ASMs) are crucial for epilepsy management but often cause cognitive side effects.
  • Understanding the molecular targets of ASMs and their relationship with cognitive function is essential for developing safer treatments.

Purpose of the Study:

  • To investigate the potential causal relationship between the expression of ASM targets and cognitive function using Mendelian randomization (MR).
  • To identify specific ASM targets that may influence cognitive outcomes.

Main Methods:

  • Collected ASM targets from the Drugbank database.
  • Utilized expression quantitative trait loci (eQTL) data to identify genetic instruments for ASM targets.
  • Performed two-sample MR and summary data-based MR analyses with genome-wide association study (GWAS) data on cognitive outcomes.
  • Conducted sensitivity analyses to ensure the robustness of findings.

Main Results:

  • Identified carbonic anhydrase 13 (CA13) as a potential causal factor linked to cognitive performance and fluid intelligence.
  • The expression of CA13, an ASM target, showed a significant association with cognitive function, independent of epilepsy.
  • 3789 single nucleotide polymorphisms (SNPs) associated with ASM targets in whole blood were extracted.

Conclusions:

  • The findings suggest CA13 may modulate cognitive function, presenting a potential target for mitigating ASM-related cognitive side effects.
  • Further functional studies are necessary to confirm causality and elucidate the mechanisms underlying the association between CA13 expression and cognitive function.